Joint (JYNT) Expected to Announce Earnings on Thursday

Joint (NASDAQ:JYNT) is projected to release its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Joint to post earnings of $0.0467 per share and revenue of $14.5730 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $14.82 million for the quarter, compared to analyst estimates of $14.50 million. Joint had a net margin of 5.72% and a return on equity of 7.00%. On average, analysts expect Joint to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Price Performance

JYNT stock opened at $8.34 on Thursday. The stock has a market cap of $118.89 million, a price-to-earnings ratio of 36.26 and a beta of 1.09. The company has a 50 day simple moving average of $8.87 and a 200 day simple moving average of $8.95. Joint has a 1 year low of $7.50 and a 1 year high of $11.75.

Analyst Upgrades and Downgrades

JYNT has been the topic of a number of research reports. Wall Street Zen cut shares of Joint from a “strong-buy” rating to a “buy” rating in a research note on Sunday, June 7th. Weiss Ratings upgraded Joint from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, June 12th. Finally, Zacks Research downgraded Joint from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $18.00.

Insider Transactions at Joint

In other Joint news, major shareholder Charles E. Jobson acquired 127,676 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average price of $8.57 per share, for a total transaction of $1,094,183.32. Following the acquisition, the insider directly owned 1,773,479 shares in the company, valued at $15,198,715.03. This represents a 7.76% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 30.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Joint

Institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets increased its position in Joint by 104.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company’s stock valued at $28,000 after acquiring an additional 1,501 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Joint by 32.3% during the second quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after purchasing an additional 1,810 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Joint by 25.9% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after purchasing an additional 1,698 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of Joint in the fourth quarter worth $124,000. Finally, Wells Fargo & Company MN increased its holdings in Joint by 78.0% in the fourth quarter. Wells Fargo & Company MN now owns 15,476 shares of the company’s stock valued at $135,000 after purchasing an additional 6,784 shares during the period. 76.88% of the stock is owned by institutional investors.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.